(Q46966228)
Statements
Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen (English)
M Buxton
N R Poulter
B Dahlöf
P S Sever
H Wedel
B Jönsson
ASCOT trial investigators